Greg Fox

In the Mekong Delta region of #Vietnam, our research team are doing incredible work to detect and prevent #tuberculosis in the community. The ACT5 trial is helping Vietnam to End Tb. @Woolcockmedical @Sydney_ID @seacsydney 🇻🇳

Warm engagement between Australian and Indonesian leaders today in Jakarta. 🇮🇩🇦🇺 PM Albanese: ‘Security is built on sovereignty of every nation and for the rules that govern all nations’ @ASEAN reuters.com/world/asia-pac…

Delighted to be back in #Hanoi 🇻🇳with our brilliant clinical trials team. A great discussion about participant safety in #tuberculosis trials, and how research partnerships can change policy and practice. @SydneyVietnam @syd_health @Control_TB #EndTB @TrialsCentre

The voices of people with a lived experience of #TB 🏥are vital to developing research that meets their needs. 😷On #WorldTBDay2025 listen to our Community Advisory Board share their voices - helping us #EndTB youtu.be/kKaP-HElKyg?si… @Control_TB

TB affects over 10 million people a year, and yet we still miss a third of new cases! Today on #WorldTBday it’s time to act. Great to bring together TB CRE @Control_TB with @MTBCMelbourne to collaborate and tackle this global pandemic #EndTB

Artificial intelligence 🩻 can be a game changer for diagnosing infectious diseases such as tuberculosis. 🦠Check out our review of the latest in AI diagnostics 👇👇 jmir.org/2025/1/e69068

Over 90% of melanomas in Australia are preventable. New immunotherapies have been a game changer for patients with melanoma. Inspiring address by Prof Georgina Long, keynote speaker @royalsocnsw @Sydney_Uni @syd_health

A visionary contribution to the future of eye health in Australia and globally from the @SnowMedical Foundation! @jcrowston @syd_health @Sydney_Uni

The Sydney Southeast Asia Centre (SSEAC) is seeking a talented academic with a passion for research partnerships in #Southeast Asia. 🌏 This new Deputy Director (Partnerships) role will enable SSEAC to expand our outstanding research partnerships across the region

The link to our individual participant data meta-analysis of two trials, also out today 👇👇 evidence.nejm.org/doi/full/10.10…

Our landmark VQUIN trial published today in New England Journal of Medicine, shows levofloxacin is safe for preventing drug-resistant #TB. A 60% lower TB incidence @ 54 weeks, in our pre-specified combined analysis with TB CHAMP in @NEJMEvidence @NEJM nejm.org/doi/full/10.10…

The seas of #SoutheastAsia connect the region both geographically and culturally. Wonderful to join @sea_greeny at the launch of the SEA-Collections digital exhibition today @seacsydney @Sydney_Uni Supported by ASEAN-Aust Centre seaexhibition.com

Exciting to recognise research successes in Vietnam 🇻🇳 at the end of year Sydney Vietnam Academic Network celebration @Sydney_Uni @seacsydney @dhutchman @_jbeardsley_ @ThuAnhNguyen_

Congratulations to Prof Nguyễn Việt Nhung for receiving the Princess Chichibu Award for his lifetime contributions to #tuberculosis care, in Vietnam 🇻🇳 and globally #UnionConf2024 @UnionConference

Partnering with people affected by #TB help ensure our research meets the needs of people who will benefit from new innovations. And as researchers, we need to learn how to work better with these communities. Great insights from @sarah_bernays @UnionConference

“What I see when I look at this map is massive injustice and failure” @Marks1Guy, President of The Union

‘We have run out of excuses - we need to #EndTB’ - breaking the chain of transmission is now possible and urgent - President @Marks1Guy at the 2024 World Conference in Lung Health @Control_TB

Excited to kick off the inaugural Sydney #Southeast_Asia Research #Innovation Symposium - hearing our amazing researches share their impacts #LeadershipForGood @Sydney_Uni @seacsydney

An incredibly productive meeting this week @WHO - thinking through how #TB programs can find the missing millions of people with #TB. 🔬🩻 to #endTB we need more screening, with better tests and to engage the general population in high-burden settings. 🏥🌍@Control_TB @Sydney_ID